A Novel Coronavirus (nCOV- 2019): A Pandemic Severe Respiratory Tract Infections by SARS COV-2 in Human

Novel Coronavirus Disease 2019 (nCOV 2019) or Coronavirus is one which is associate communicable disease amongst variety of viruses that causes cold, fever, difficulty in breathing and ultimately death. The viruses cause metabolism infections, together with the mundane cold, that square measure usually delicate, although a lot of occasional forms like respiratory illness caused by SARS-CoV-2, the illness is that the reason for the 2019-20 coronavirus irruption. It's primarily unfolded between individuals by diminutive droplets from infected people once they breathe or cough. Individuals could have few symptoms or develop febrility, cough, and shortness of breath. Whereas Feb 2020, different countries together with European country Asian Countries enclosed within the list. Antiviral drugs being tested embrace antimalarial drug, the ribonucleic acid enzyme substance remdesivir, and triazavirin, Umifenovir (Arbidol) and darunavir were planned. Remdesivir and antimalarial drug effectively inhibit the coronavirus in vitro. Favilavir approved as experimental corona virus drug. The objective of this review article to provide basic knowledge & preliminary opinion and to provide an advice which can be proved as the best mantra for defeating nCOV. Thus this review aims to throw light to the new and exciting areas of Virology, Replication cycle of corona virus, sign & symptoms and diagnosis, Spreading of corona virus, Structural biology of corona virus, the ways of treatment with alternative medicines other than antiviral drugs, and prevention in its early stage of COVID-19, and also Current Research on Corona.